NZ213984A - Vaccinia virus protein analogues with growth factor activity produced recombinantly - Google Patents

Vaccinia virus protein analogues with growth factor activity produced recombinantly

Info

Publication number
NZ213984A
NZ213984A NZ213984A NZ21398485A NZ213984A NZ 213984 A NZ213984 A NZ 213984A NZ 213984 A NZ213984 A NZ 213984A NZ 21398485 A NZ21398485 A NZ 21398485A NZ 213984 A NZ213984 A NZ 213984A
Authority
NZ
New Zealand
Prior art keywords
amino acid
carbon atoms
neutral
aliphatic
amino acids
Prior art date
Application number
NZ213984A
Other languages
English (en)
Inventor
Joseph P Brown
Daniel R Twardzik
Hans Todaro George J Marquardt
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NZ213984A publication Critical patent/NZ213984A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ213984A 1984-10-30 1985-10-29 Vaccinia virus protein analogues with growth factor activity produced recombinantly NZ213984A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66652084A 1984-10-30 1984-10-30

Publications (1)

Publication Number Publication Date
NZ213984A true NZ213984A (en) 1991-05-28

Family

ID=24674411

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ213984A NZ213984A (en) 1984-10-30 1985-10-29 Vaccinia virus protein analogues with growth factor activity produced recombinantly

Country Status (12)

Country Link
EP (1) EP0199769A4 (enrdf_load_html_response)
JP (1) JPS62501071A (enrdf_load_html_response)
AU (2) AU600433B2 (enrdf_load_html_response)
ES (7) ES8702925A1 (enrdf_load_html_response)
FI (1) FI862734L (enrdf_load_html_response)
GR (1) GR852610B (enrdf_load_html_response)
IL (1) IL76866A0 (enrdf_load_html_response)
NO (1) NO862613L (enrdf_load_html_response)
NZ (1) NZ213984A (enrdf_load_html_response)
PH (2) PH24603A (enrdf_load_html_response)
PT (1) PT81408B (enrdf_load_html_response)
WO (1) WO1986002650A1 (enrdf_load_html_response)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US4863899A (en) * 1983-05-09 1989-09-05 Todaro George J Biologically active polypeptides
KR950001993B1 (ko) * 1985-12-18 1995-03-08 마이크로제네시스,인코포레이티드 B형 간염 표면항원의 제조방법
FI891308A7 (fi) * 1988-03-24 1989-09-25 Oncogen Uudet polypeptidit, joilla on kasvutekijäaktiivisuutta sekä polypeptideitä koodittavat nukleiinihapposekvenssit

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE38892B1 (en) * 1973-03-28 1978-06-21 Ici Ltd Pharmaceutical compositions
US4366246A (en) * 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4230691A (en) * 1978-05-23 1980-10-28 The Massachusetts General Hospital Nerve growth factor antibody and process
IE53166B1 (en) * 1980-08-05 1988-08-03 Searle & Co Synthetic urogastrone gene,corresponding plasmid recombinants,transformed cells,production thereof and urogastrone expression
JPH064673B2 (ja) * 1980-11-10 1994-01-19 ゲネンテツク・インコ−ポレ−テツド ハイブリド型ヒト白血球インタフエロン
WO1985002198A1 (en) * 1983-11-01 1985-05-23 Amgen Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production

Also Published As

Publication number Publication date
AU4868785A (en) 1986-05-15
PT81408A (en) 1985-11-01
JPS62501071A (ja) 1987-04-30
ES557710A0 (es) 1988-01-01
PT81408B (pt) 1987-11-11
EP0199769A4 (en) 1989-11-29
EP0199769A1 (en) 1986-11-05
ES548316A0 (es) 1987-01-16
ES557708A0 (es) 1988-01-01
WO1986002650A1 (en) 1986-05-09
FI862734A0 (fi) 1986-06-26
NO862613D0 (no) 1986-06-27
AU6655190A (en) 1991-01-24
FI862734A7 (fi) 1986-06-26
ES8707741A1 (es) 1987-08-16
GR852610B (enrdf_load_html_response) 1986-03-04
ES554629A0 (es) 1988-04-01
ES8802074A1 (es) 1988-03-16
AU600433B2 (en) 1990-08-16
ES554628A0 (es) 1988-03-16
ES557145A0 (es) 1987-08-16
ES8802061A1 (es) 1988-03-16
PH24603A (en) 1990-08-17
ES8702925A1 (es) 1987-01-16
ES554630A0 (es) 1988-03-16
FI862734L (fi) 1986-06-26
IL76866A0 (en) 1986-02-28
AU633377B2 (en) 1993-01-28
PH25794A (enrdf_load_html_response) 1991-11-05
ES8802185A1 (es) 1988-04-01
NO862613L (no) 1986-06-27
ES8801379A1 (es) 1988-01-01
ES8801378A1 (es) 1988-01-01

Similar Documents

Publication Publication Date Title
US5830995A (en) Fanphiregulins: a family of heparin-binding epithelial cell growth factors
EP2107109B1 (en) Recombinant vascular endothelial cell growth factor D (VEGF-D)
US5221620A (en) Cloning and expression of transforming growth factor β2
US20090093400A1 (en) Truncated keratinocyte growth factor (KGF) having increased biological activity
IE881597L (en) Expression of Human Proapolipoprotein A-I
CA2032675A1 (en) Platelet-derived growth factor b chain analogs and method for homogeneous production thereof
US5115096A (en) Amphiregulin: a bifunctional growth modulating glycoprotein
SK284391B6 (sk) Mutantné proteíny ľudského interleukínu-4 ako antagonisty alebo parciálne agonisty ľudského interleukínu-4, liečivá, ktoré ich obsahujú, a použitie
US5359033A (en) Cleaved dimers of mullerian inhibiting substance-like polypeptides
HUT52550A (en) Process for production of a new, tgf-betha 1/betha 2 chimera betha transformating increasing factor
EP0728142A1 (en) Novel antler-derived bone growth factors
AU719526B2 (en) New form of amphiregulin, methods for producing and using the same and compositions comprising the same
AU600433B2 (en) Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
Giese et al. Expression and purification of biologically active v-sis/platelet-derived growth factor B protein by using a baculovirus vector system
US5912325A (en) Biologically active porcine somatotropin polypeptides and methods of using the same
GB2219799A (en) Epidermal growth receptor-binding polypeptides
PH25991A (en) Antibodies to novel polypeptide having growth factor activity
WO1991009057A1 (en) Novel proteins with oncostatin m activity and process for their preparation
US6080845A (en) Monoclonal antibody against utricular epithelium
CA1326639C (en) Nucleic acid encoding tgf-.beta. and its uses